U · A
Unknown Author
January 22, 2026
Milbank Advises Lenders in $225M Revolving Loan Facility for Global Medical Device Company LivaNova
1 min
AI-made summary
- Milbank LLP advised the lenders in a $225 million revolving loan facility provided to LivaNova USA, Inc., the US subsidiary of LivaNova PLC
- The loan proceeds are designated for general corporate purposes
- LivaNova is a global medical device company based in London
- The Milbank legal team was led by partner Lauren Hanrahan, with support from special counsel Gabrielle Paolini Webster and associates Julia Wennberg, Michael Beyda, and Joseph Principato.
Milbank LLP represented the lenders in connection with the provision of $225 million revolving loan facilities for LivaNova USA, Inc., the US subsidiary of LivaNova PLC (Nasdaq: LIVN) (âLivaNovaâ). The proceeds of the facilities will be used for general corporate purposes.
LivaNova is a global medical device company headquartered in London.
The Milbank team was led by New York-based Global Leveraged Finance partner Lauren Hanrahan with assistance from special counsel Gabrielle Paolini Webster and associates Julia Wennberg, Michael Beyda and Joseph Principato.
U
Article Author
Unknown Author
The Sponsor